A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.
Nov 27, 2024
0
12
Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of aggressiveness. It's also the second leading cause of cancer death, behind only lung cancer.
Nov 25, 2024
0
0
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Nov 20, 2024
0
6
Mobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more affordably than GPs, according to new research.
Nov 18, 2024
0
0
A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has investigated prostate tumors and developed an advanced, realistic, three-dimensional model of prostate ...
Nov 14, 2024
0
53
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term ...
Nov 13, 2024
0
0
The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other targets to treat prostate ...
Nov 12, 2024
0
0
Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in slowing and even preventing prostate cancer from spreading among men who joined a phase 2 clinical ...
Nov 12, 2024
0
101
Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending ...
Nov 11, 2024
0
13
Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumor is still responsible for one in eight male cancer deaths in Austria alone.
Nov 8, 2024
0
0
